ADMA BIOLOGICS, INC. Interest Expense, Other
ADMA BIOLOGICS, INC. (ADMA) reported Interest Expense, Other of -$8.42 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-13.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpenseOther · last filed 2020-03-13
- ADMA BIOLOGICS, INC. interest expense, other for the quarter ending 2019-03-31 was $225.00K, a 0.00% change year-over-year.
- ADMA BIOLOGICS, INC. interest expense, other for the quarter ending 2018-06-30 was $225.00K, a 275.00% increase year-over-year.
- ADMA BIOLOGICS, INC. interest expense, other for the quarter ending 2018-03-31 was $225.00K.
- ADMA BIOLOGICS, INC. interest expense, other for the quarter ending 2017-12-31 was $230.00K.
- ADMA BIOLOGICS, INC. interest expense, other for fiscal 2019 was -$8.42M.
- ADMA BIOLOGICS, INC. interest expense, other for fiscal 2018 was -$5.45M, a 1148.94% decline from fiscal 2017.
- ADMA BIOLOGICS, INC. interest expense, other for fiscal 2017 was $520.00K.
- ADMA BIOLOGICS, INC. interest expense, other for fiscal 2016 was $0.00.
| Period end | Interest Expense, Other 3 month | Interest Expense, Other 6 month | Interest Expense, Other 9 month | Interest Expense, Other 12 month | Interest Expense, Other 12 month as first filed |
|---|---|---|---|---|---|
| 2019-12-31 | -$8.42M 10-K · filed 2020-03-13 | ||||
| 2019-03-31 | $225.00K 10-Q · filed 2019-05-08 | ||||
| 2018-12-31 | -$5.45M 10-K · filed 2020-03-13 | $912.50K 10-K · filed 2019-03-13 | |||
| 2018-06-30 | $225.00K 10-Q · filed 2018-08-10 | $450.00K 10-Q · filed 2018-08-10 | $680.00K derived: sum of 3 quarters · filed 2019-05-08 | $910.00K derived: sum of 4 quarters · filed 2019-05-08 | |
| 2018-03-31 | $225.00K 10-Q · filed 2019-05-08 | $455.00K derived: sum of 2 quarters · filed 2019-05-08 | $685.00K derived: sum of 3 quarters · filed 2019-05-08 | $745.00K derived: sum of 4 quarters · filed 2019-05-08 | |
| 2017-12-31 | $230.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | $460.00K derived: sum of 2 quarters · filed 2019-03-13 | $520.00K derived: sum of 3 quarters · filed 2019-03-13 | $520.00K 10-K · filed 2019-03-13 | |
| 2017-09-30 | $230.00K 10-Q · filed 2017-11-03 | $290.00K derived: sum of 2 quarters · filed 2018-08-10 | $290.00K 10-Q · filed 2017-11-03 | $290.00K derived: sum of 4 quarters · filed 2018-08-10 | |
| 2017-06-30 | $60.00K 10-Q · filed 2018-08-10 | $60.00K 10-Q · filed 2018-08-10 | $60.00K derived: sum of 3 quarters · filed 2018-08-10 | $60.00K derived: sum of 4 quarters · filed 2018-08-10 | |
| 2017-03-31 | $0.00 10-Q · filed 2018-05-14 | $0.00 derived: sum of 2 quarters · filed 2018-05-14 | $0.00 derived: sum of 3 quarters · filed 2018-05-14 | $0.00 derived: sum of 4 quarters · filed 2018-05-14 | |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29 | $0.00 derived: sum of 2 quarters · filed 2018-03-29 | $0.00 derived: sum of 3 quarters · filed 2018-03-29 | $0.00 10-K · filed 2018-03-29 | |
| 2016-09-30 | $0.00 10-Q · filed 2017-11-03 | $0.00 derived: sum of 2 quarters · filed 2017-11-03 | $0.00 10-Q · filed 2017-11-03 | ||
| 2016-06-30 | $0.00 10-Q · filed 2017-08-11 | $0.00 10-Q · filed 2017-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |